StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.75−0.18 (-0.64%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Zenas BioPharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Zenas BioPharma's total debt was $223.24M at Sep 30, 2026. For fiscal 2025 it was $78.64M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.64M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$223.24M+205.9%
Q2 FY2026Jun 30, 2026$222.96M–
Q1 FY2026Mar 31, 2026$193.63M–
Q4 FY2025Dec 31, 2025$78.64M–
Q3 FY2025Sep 30, 2025$72.99M–

More Zenas BioPharma figures

See a number that looks wrong?